LifeSciences BC > News > Member Announcements

Introducing Cytiva – Global Life Sciences Leader

April 7, 2020
Cytiva

New Danaher operating company created following completion of $21.4B acquisition by Danaher Corporation Previously GE Healthcare Life Sciences, Cytiva will help accelerate growth and innovation in biological therapies Leading life sciences brands such as ÄKTA, Amersham, HyClone, MabSelect and Whatman are part of Cytiva Cytiva, a global provider of technologies and services that help advance … Continue reading Introducing Cytiva – Global Life Sciences Leader

MSFHR Launches COVID-19 Research Response Fund & First Call For Proposals

April 6, 2020
Michael Smith Foundation for Health Research

MSFHR SHIFTS COMPETITION DEADLINES TO SUPPORT APPLICANTS INVOLVED IN COVID-19 EMERGENCY RESPONSE April 06, 2020 The MSFHR COVID-19 Research Response Fund opens today (April 6) with the first of several funding calls for BC researchers. Researchers or research teams interested in applying to this first call should have projects that address one or more of the following: … Continue reading MSFHR Launches COVID-19 Research Response Fund & First Call For Proposals

Qu Biologics publishes landmark studies showing cells of the innate immune system can be directed to target organ sites to prevent and clear pathology and infection

April 6, 2020
Qu Biologics Inc.

Vancouver, British Columbia – April 6th, 2020 – Qu Biologics Inc. (Qu), a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of microbial-based immunotherapies designed to restore the body’s innate immune system, has published for the first time the basis of their first-in class therapy. The series of studies, published this week in … Continue reading Qu Biologics publishes landmark studies showing cells of the innate immune system can be directed to target organ sites to prevent and clear pathology and infection

CALL TO ACTION COVID 19 ALL BC MEDICAL SUPPLIERS, LABORATORIES AND SERVICE PROVIDERS

April 6, 2020
LifeSciences BC

April 6, 2020 – Vancouver, B.C. – As COVID-19 places a strain on urgent patient care and therapeutic treatments, a critical need has developed for medical supplies and services that are indispensable on the front line. To address this crucial need, LifeSciences BC has taken on the role of identifying, creating and collecting information to … Continue reading CALL TO ACTION COVID 19 ALL BC MEDICAL SUPPLIERS, LABORATORIES AND SERVICE PROVIDERS

COVID-19 Open Innovation Challenge

April 6, 2020
ROCHE

Roche Canada is committed to working in partnership with our Canadian community to develop solutions to the challenges of the COVID-19 pandemic The SARS-CoV-2 (COVID-19) pandemic is impacting the daily lives of everyone around the world. We are isolated within our communities, we are exceeding the capacity of our health systems, and we are struggling … Continue reading COVID-19 Open Innovation Challenge

Innovative Medicines Canada members donate 100,000 masks to help protect front-line healthcare workers battling COVID-19

April 2, 2020
Innovative Medicines Canada (IMC)

Ottawa, April 1, 2020—Members of Innovative Medicines Canada (IMC) are continuing their efforts in the fight against COVID-19 by donating 100,000 N95 masks for front-line healthcare workers battling the virus. The donation is in response to the federal government’s request for additional protective equipment. The masks are being shipped to the Public Health Agency of … Continue reading Innovative Medicines Canada members donate 100,000 masks to help protect front-line healthcare workers battling COVID-19

InMed Announces Completion of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects

April 2, 2020
InMed Pharmaceuticals Inc.

Vancouver, BC – March 31, 2020 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol (“CBN”), today announced that all subjects participating in its 755-101-HV Phase 1 clinical trial have … Continue reading InMed Announces Completion of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects

Biotech Primer Courses

April 1, 2020
adMare BioInnovations

adMare & Biotech Primer – Drug Discovery and Development Course Application We are pleased to have partnered with Biotech Primer to offer complimentary access to their on-line Drug Discovery and Development courses for up to 100 innovative life scientists. We are pleased to extend this offer to Masters, Ph.D., or Post-Doc researchers in the first … Continue reading Biotech Primer Courses

2020 Canada Gairdner Awards Recognize World-Renowned Scientists For Transformative Contributions To Research That Impact Human Health

March 31, 2020
Gairdner Foundation

TORONTO, ON (March 31 2020) – The Gairdner Foundation is pleased to announce the 2020 Canada Gairdner Award laureates, recognizing some of the world’s most significant biomedical research and discoveries. During these challenging times, we believe it is important to celebrate scientists and innovators from around the world and commend them for their tireless efforts … Continue reading 2020 Canada Gairdner Awards Recognize World-Renowned Scientists For Transformative Contributions To Research That Impact Human Health

Global Biotechnology Firm STEMCELL Launches COVID-19 Staff Safety App

March 31, 2020
STEMCELL Technologies Inc.

App to be available as a free-to-use template for the OutSystems developer community BOSTON — March 31, 2020 — OutSystems announced that STEMCELL Technologies has launched its “My Status” app to help keep STEMCELL staff safe during the COVID-19 pandemic. The app, developed in one day and built with the OutSystems low-code development platform, helps … Continue reading Global Biotechnology Firm STEMCELL Launches COVID-19 Staff Safety App